Abstract:Tongue squamous cell carcinoma (TSCC) is a prevalent cancer of the oral cavity. Survival metrics are usually unsatisfactory, even using combined treatment with surgery, radiation, and chemotherapy. Immune checkpoint inhibitors can prolong survival, especially in patients with recurrent or metastatic disease. However, there are few effective biomarkers to provide prognosis and guide immunotherapy. Here, we utilized weighted gene co-expression network analysis to identify the co-expression module and selected the turquoise module for further scrutiny. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses revealed the innate pathways. The findings indicated that cell junction organization, response to topologically incorrect protein, and regulation of cell adhesion pathways may be essential. Eleven crucial predictive genes ( PLXNB1 , N4BP3 , KDELR2 , INTS8 , PLAU , PPFIBP2 , OAF , LMF1 , IL34 , ZFP3 , and MAP7D3 ) were used to establish a risk model based on Cox and LASSO analyses of The Cancer Genome Atlas and GSE65858 databases (regarding overall survival). Kaplan–Meier analysis and receiver operating characteristic curve suggested that the risk model had better prognostic effectiveness than other clinical traits. Consensus clustering was used to classify TSCC samples into two groups with significantly different survival rates. ESTIMATE and CIBERSORT were used to display the immune landscape of TSCC and indicate the stromal score; specific types of immune cells, including naïve B cells, plasma cells, CD8 T cells, CD4 memory resting and memory activated T cells, follicular helper T cells, and T regulatory cells, may influence the heterogeneous immune microenvironment in TSCC. To further identify hub genes, we downloaded GEO datasets (GSE41613 and GSE31056) and successfully validated the risk model. Two hub genes ( PLAU and PPFIBP2 ) were strongly associated with CD4+ and CD8+ T cells and programmed cell death protein 1 (PD1) and PD-ligand 1.

CBX3/HP1γ is Upregulated in Tongue Squamous Cell Carcinoma and is Associated with an Unfavorable Prognosis

CBX3 Promotes Tumor Proliferation by Regulating G1/S Phase Via P21 Downregulation and Associates with Poor Prognosis in Tongue Squamous Cell Carcinoma.

[Expression of Notch1 and Epidermal Growth Factor Receptor in Human Tongue Squamous Cell Carcinoma and Precancerous Lesion].

CBX3/HP1γ Promotes Tumor Proliferation and Predicts Poor Survival in Hepatocellular Carcinoma

Bmi1 Drives Stem-Like Properties and is Associated with Migration, Invasion, and Poor Prognosis in Tongue Squamous Cell Carcinoma

MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma

High SOX8 Expression Promotes Tumor Growth and Predicts Poor Prognosis Through GOLPH3 Signaling in Tongue Squamous Cell Carcinoma

Overexpression of Thioredoxin System Proteins Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Tongue.

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma

Correlation of ALDH1, CD44, OCT4 and SOX2 in Tongue Squamous Cell Carcinoma and Their Association with Disease Progression and Prognosis.

CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma

Overexpression of Hippo Pathway Effector TAZ in Tongue Squamous Cell Carcinoma: Correlation with Clinicopathological Features and Patients' Prognosis.

Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma

Hypoxia-inducible Factor-1 Alpha, in Association with TWIST2 and SNIP1, is a Critical Prognostic Factor in Patients with Tongue Squamous Cell Carcinoma.

PBX3 is Associated with Proliferation and Poor Prognosis in Patients with Cervical Cancer.

SCUBE3 exerts a tumor-promoting effect in tongue squamous cell carcinoma by promoting CEBPA binding to the CCL2 promoter

Identiﬁcation of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.

Expression of HMGB1 in human tongue squamouse cell carcinoma

CDH3 is Associated with Poor Prognosis by Promoting the Malignancy and Chemoresistance in Oral Squamous Cell Carcinoma.

High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.

Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Unfavorable Prognosis in Tongue Squamous Cell Carcinoma.